imatinib mesylate has been researched along with Lentigines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, M; Ieta, K; Ishida-Yamamoto, A; Ishikawa, O; Shibusawa, K; Shimizu, A; Tamura, A | 1 |
| Chandrashekar, L; Colombo, EA; Fontana, L; Gervasini, C; Gupta, D; Kate, V; Larizza, L; Rajappa, M; Rajendiran, KS; Sreenath, GS; Thappa, DM | 1 |
| Campbell, T; Felsten, L; Moore, J | 1 |
3 other study(ies) available for imatinib mesylate and Lentigines
| Article | Year |
|---|---|
Generalized lentigines associated with familial gastrointestinal stromal tumors dramatically improved by imatinib treatment.
Topics: Chemotherapy, Adjuvant; Dermoscopy; DNA Mutational Analysis; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Gastrectomy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gastroscopy; Humans; Imatinib Mesylate; Lentigo; Middle Aged; Neoplastic Syndromes, Hereditary; Point Mutation; Proto-Oncogene Proteins c-kit; Skin; Stomach; Treatment Outcome | 2020 |
Familial gastrointestinal stromal tumors, lentigines, and café-au-lait macules associated with germline c-kit mutation treated with imatinib.
Topics: Adult; Antineoplastic Agents; Cafe-au-Lait Spots; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Germ-Line Mutation; Humans; Imatinib Mesylate; Lentigo; Male; Pedigree; Proto-Oncogene Proteins c-kit | 2017 |
Disappearance of lentigines in a patient receiving imatinib treatment for familial gastrointestinal stromal tumor syndrome.
Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Colectomy; Dysplastic Nevus Syndrome; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lentigo; Middle Aged; Piperazines; Pyrimidines; Risk Assessment; Treatment Outcome | 2009 |